1.The STAT3 in Glucose Homeostasis.
Bon Jeong KU ; Su Hyeon PARK ; Koon Soon KIM ; Young Kun LIM ; Min Ho SHONG
Journal of Korean Society of Endocrinology 2004;19(3):274-280
No abstract avaiable.
Glucose*
;
Homeostasis*
2.Association between nutritional status, sarcopenia, and frailty in rural elders
Journal of Agricultural Medicine & Community Health 2021;46(1):23-31
Objectives:
Frailty and sarcopenia are recent important concepts in elder health care. Sarcopenia is the most important factor influencing frailty, and exercise and nutritional status are known to affect sarcopenia. The purpose of this study was to identify the relationship between nutritional status, sarcopenia, and frailty.
Methods:
This study was a cross-sectional design. The subjects of this study were 411 elderly people aged 65 or older from 10 villages in Gyeongnam. The survey tools were the K-FRAIL for frailty, the GDS-SF for depression, the SARC-F questionnaire for sarcopenia, and the DETERMINE for nutritional status. Frequency analysis, the chi-square test, and multiple logistic regression analysis were performed using the SPSS 25.0 program.
Results:
As a result of the chi-square test, there was a significant difference in the nutritional status and the frailty proportion (p<0.001), and there was a significant difference between frailty and suspected sarcopenia (p<0.001). After adjustment, nutritional status was significantly associated with sarcopenia (OR=2.946, p<0.001). In addition, nutritional status was significantly associated with frailty (OR=2.958, p<0.001), and sarcopenia also had a significant effect on frailty (OR=5.898, p<0.001). Finally, even after including sarcopenia, nutritional status had a significant effect on frailty (OR=2.246, p=0.002).
Conclusions
Nutritional status can have both a direct effect on frailty and an indirect effect through sarcopenia, and it was found that sarcopenia also affects frailty. Therefore, it is necessary to evaluate sarcopenia and nutritional status and to evaluate their levels in the elderly and to take appropriate interventions.
3.Analysis of postpneumonectomy complications.
Gang Bae HUH ; Sung Rae CHO ; Su Hyeon KIM ; Hyeon Cheol HA ; Sung Dal PARK ; Jae Sung LEE ; Song Myung KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(8):613-619
No abstract available.
4.Determination of Mineral Components in the Cultivation Substrates of Edible Mushrooms and Their Uptake into Fruiting Bodies.
Chang Yun LEE ; Jeong Eun PARK ; Bo Bae KIM ; Sun Mi KIM ; Hyeon Su RO
Mycobiology 2009;37(2):109-113
The mineral contents of the cultivation substrates, fruiting bodies of the mushrooms, and the postharvest cultivation substrates were determined in cultivated edible mushrooms Pleurotus eryngii, Flammulina velutipes, and Hypsizigus marmoreus. The major mineral elements both in the cultivation substrates and in the fruiting bodies were K, Mg, Ca, and Na. Potassium was particularly abundant ranging 10~13 g/kg in the cultivation substrates and 26~30 g/kg in the fruiting bodies. On the contrary, the calcium content in the fruiting bodies was very low despite high concentrations in the cultivation substrates, indicating Ca in the cultivation substrates is in a less bio-available form or the mushrooms do not have efficient Ca uptake channels. Among the minor mineral elements determined in this experiment, Cu, Zn, and Ni showed high percentage of transfer from the cultivation substrates to the fruiting bodies. It is noteworthy that the mineral contents in the postharvest cultivation substrates were not changed significantly which implies that the spent cultivation substrates are nutritionally intact in terms of mineral contents and thus can be recycled as mineral sources and animal feeds.
Agaricales
;
Animal Feed
;
Calcium
;
Flammulina
;
Fruit
;
Pleurotus
;
Potassium
6.Hemolytic Uremic Syndrome Occurred after Esophagectomy: A Case Report.
Su Hyeon PARK ; Sung Tae JEONG ; Seok Jai KIM ; Hong Beom BAE ; Sung Su CHUNG ; Sang Hyun KWAK
The Korean Journal of Critical Care Medicine 2007;22(1):42-47
Hemolytic uremic syndrome is an unusual and uncommon disease in adults but more common in children, which is defined by the triad of acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia. We report a 64-year-old man who developed hemolytic uremic syndrome after esophagectomy and esophagogastrostomy due to esophageal cancer. We treated him using continuous renal replacement therapy and plasmapheresis with large volume fresh frozen plasma transfusion for 9 days. We could not find the cause of hemolytic uremic syndrome, and so finally concluded that it is idiopathic. Bleeding continuously without a particular reason after an operation, it needs an early diagnosis and treatment with considering a possibility of the hemolytic uremic syndrome.
Acute Kidney Injury
;
Adult
;
Anemia, Hemolytic
;
Child
;
Early Diagnosis
;
Esophageal Neoplasms
;
Esophagectomy*
;
Hemolytic-Uremic Syndrome*
;
Hemorrhage
;
Humans
;
Middle Aged
;
Plasma
;
Plasmapheresis
;
Renal Replacement Therapy
;
Thrombocytopenia
7.Exploding Head Syndrome.
Sang Jun PARK ; Su Hyeon KIM ; Kee Hyung PARK ; Young Hee SUNG ; Yeong Bae LEE ; Hyeon Mi PARK ; Dong Jin SHIN
Journal of the Korean Neurological Association 2009;27(2):170-173
Exploding head syndrome (EHS) is characterized by a sudden loud imagined noise or sense of a violent explosion in the head occurring as the patient is falling asleep or waking during the night. EHS is classified as "other parasomnia" on the ICSD-2 (International Classification of Sleep Disorders), and the neurophysiologic mechanisms underlying this hypnagogic phenomenon are unknown. EHS is a rare type of other parasomnia that has not been reported in Korea. We report two cases of EHS that presented with typical clinical symptoms.
Explosions
;
Head
;
Humans
;
Korea
;
Noise
;
Parasomnias
8.Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy.
Young Sun SUH ; Seung Ki KWOK ; Ji Hyeon JU ; Kyung Su PARK ; Sung Hwan PARK ; Chong Hyeon YOON
Journal of Korean Medical Science 2014;29(1):38-42
There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of TNFalpha inhibitors due to active tuberculosis (TB). We evaluated the safety of restarting anti-TNFalpha therapy in patients with TNFalpha-associated TB. We used data of 1,012 patients with RA or AS treated with TNFalpha inhibitors at Seoul St. Mary's Hospital between January 2003 and July 2013 to identify patients who developed active TB. Demographic and clinical data including the results of tuberculin skin tests (TST) and interferon-gamma releasing assays (IGRA) were collected. Fifteen patients developed active TB. Five cases were occurred in RA and 10 cases in AS. Nine of 15 patients had a negative TST or IGRA and 6 TST-positive patients had received prophylaxis prior to initiating anti-TNFalpha therapy. All patients discontinued TNFalpha inhibitors with starting the treatment of TB. Eight patients were re-administered TNFalpha inhibitors due to disease flares and promptly improved without recurrence of TB. TNFalpha inhibitors could be safely resumed after starting anti-TB regimen in patients with RA or AS.
Adult
;
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use
;
Antibodies, Monoclonal/adverse effects/therapeutic use
;
Antibodies, Monoclonal, Humanized/adverse effects/therapeutic use
;
Antirheumatic Agents/adverse effects/therapeutic use
;
Arthritis, Rheumatoid/*drug therapy
;
Enzyme Inhibitors/adverse effects/therapeutic use
;
Female
;
Humans
;
Hydroxychloroquine/adverse effects/therapeutic use
;
Immunoglobulin G/adverse effects/therapeutic use
;
Immunosuppressive Agents/adverse effects/*therapeutic use
;
Interferon-gamma Release Tests
;
Male
;
Methotrexate/adverse effects/therapeutic use
;
Middle Aged
;
Mycobacterium tuberculosis/isolation & purification
;
Receptors, Tumor Necrosis Factor/therapeutic use
;
Retrospective Studies
;
Spondylitis, Ankylosing/*drug therapy
;
Tuberculin Test
;
Tuberculosis/*chemically induced/microbiology
;
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
9.Erratum: Correction of Notes. Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy.
Young Sun SUH ; Seung ki KWOK ; Ji Hyeon JU ; Kyung Su PARK ; Sung Hwan PARK ; Chong Hyeon YOON
Journal of Korean Medical Science 2014;29(3):460-460
We found an error in our published article.
10.Multiple Cystic Lymphangiomas of the Penis, Scrotum and Lower Abdomen.
Hyeong Gon KIM ; Jeong Su PARK ; Hyeon Seok YANG ; Je Hee KIM ; Won Hee PARK
Korean Journal of Urology 2002;43(11):1001-1002
Lymphangiomas result from a failure of lymphatic drainage into the venous system due to atresia or an insufficiency of the efferent lymphatic channels. The neck and axillary regions are most commonly affected, while the condition is rarely found in the inguinal area, scrotum, retroperitoneal space, abdominal viscera, arm, pelvis or bones. We report a case of a cystic lymphangioma of the lower abdomen, penis and scrotum in a 29-year-old man.
Abdomen*
;
Adult
;
Arm
;
Drainage
;
Humans
;
Lymphangioma
;
Lymphangioma, Cystic*
;
Male
;
Neck
;
Pelvis
;
Penis*
;
Retroperitoneal Space
;
Scrotum*
;
Viscera